day 1 agenda

Scientific Program
     Day -1: June (20, 2024)
 Meeting Hall - Amsterdam
Registrations Open (08:00-09:00)
Opening Ceremony (09:00-09:15)
Moderator: Jennie R Lill, Genentech Inc., United States
Keynote Talks
Mohamed El-Far,
Mansoura University,
Egypt
09:15-09:45 Title: EPhotodynamic Therapy (PDT) of Tumors from Ancient Egyptians to Present: An Overview of Our Four Decades Experience
     
Maria J Nieto,
Northwell Health Cancer Institute,
United States
09:45-10:15 Title: Analysis of Updates in Multiple Myeloma Treatment and Management
     
Yifan Li,
Shanxi Cancer Hospital,
China
10:15-10:45 Title: Tumor size>5cm is a line of demarcation of mortality and progression of gastric cancer after D2+gastrectomy for Chinese population  
     
Group Photo & Refreshment Break (10:45-11:00)
Scientific Session I
Morning Session:
Session Chair:
Yifan Li, Shanxi Cancer Hospital, China
&
Maria J Nieto, Northwell Health Cancer Institute, United States
     
Jennie R Lill,
Genentech Inc.,
United States
11:00-11:20 Title: Bioanalytical & Machine Learning Advances: Enhancing our Personalized Cancer Vaccine Platform
     
Eric E. Kelley,
West Virginai University,
United States
11:20-11:40 Title: If elevated xanthine oxidoreductase (XOR) and uric acid levels are protective during hemolysis, then are we treating tumor lysis syndrome properly
     
Yohei Kawasaki,
Akita University Graduate School of Medicine,
Japan
11:40-12:00 Title: The amino acid transporter LAT1 as a molecular target for the treatment of head and neck squamous cell carcinoma
     
Mauricio Quimbaya,
Pontifical Javeriana University Cali,
Colombia
12:00-12:20 Title: Use of Arabidopsis thaliana as a model to understand specific carcinogenic events
     
Mojgan Najafzadeh,
University of Bradford,
United Kingdom
12:20-12:40 Title: A promising approach to detecting cancer at an early stage 
     
Hirokazu Uemura,
Nara Medical University,
Japan
12:40-13:00 Title: Evaluation of usefulness of tongue pressure measuring device for dysphagia associated with treatment of patients with head and neck cancer (ELEVATE trial)
     
(13:00-14:00) Lunch Break @ Restaurant 
Scientific Session II
Afternoon Session
  Session Chairs:
Shunfu Hu, Southern Illinois University Edwardsville, United States
(&)
Mojgan Najafzadeh,
University of Bradford, United Kingdom
     
Maya Suzuki,
Akita University Graduate School of Medicine,
Japan
14:00-14:20 Title: A curcumin analogue GO-Y030 depletes cancer stem cells by inhibiting the interaction between the HSP70/HSP40 complex and its substrates 
     
Zhao Zhang,
Mayo Clinic Florida,
United States
14:20-14:40 Title: Tailoring Imaging Criteria: A Guide for Ordering Physicians in Tumor Diagnosis and Management
     
Shunfu Hu,
Southern Illinois University Edwardsville,
United States
14:40-15:00 Title: Spatial and Statistical Analyses of the Cancer Mortality Rates from 2008 to 2021 in Illinois, USA
     
Gunnar L G Soderqvist,
Karolinska Institutet, Stockholm,
Sweden
15:00-15:20 Title: Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women
     
Roger A. Vertrees,
Verthermia Acquisitions, Inc.,
United States
15:20-15:40 Title: Hyperthermic Extracorporeal Applied Tumor Therapy (HEATT™): An Update of Patient Experiences
     
Paula Castro Sanchez,
Miguel Hernandez University,
Spain
15:40-16:00 Title: Genetic variants and enzyme activity in citidin deaminase: Relationship with capecitabine toxicity and recommendation for dose adjustment
     
Refreshment Break(16:00-16:10)
     
Masoud Mohammadnezhad,
University of Bradford,
United Kingdom
16:10-16:30 Title: Epidemiology of Cervical Cancer screening in Fiji
     
Ying Shen,
Shanghai Jiao Tong University School of Medicine,
China
16:30-16:50 Title: Targeting metabolic enzymes to suppress lung cancer progression
     
Sharmistha Dey,
All India Institute of Medical Science,
India
16:50-17:10 Title: Diagnostic significance of serum p38 Isoforms (p38α, p38β, p38γ, p38δ) in Head and Neck Squamous Cell Carcinoma
     
Youfu Luo,
Sichuan University,
China
17:10-17:30 Title: Targeting Human Caseinolytic Protease P (ClpP) for Cancer Therapy
     
Pannel Discussions
Conference Hotel:
Hotel Duo,
Teplická 492, 190 00
Prag 9, Czech Republic.
If any one interested to attend the conference or to book your speaker slot, please send an email to cancercongress@innovincinternational.com

day 2 agenda

Scientific Program
     Day -2: June (21, 2024)
 Meeting Hall - Amsterdam
Moderator: Natalia Neparidze, Yale University,United States
Keynote Talks
Slawomir Lukomski,
West Virginia University,
United States
09:00-09:30 Title: Scl1-mediated anti-tumor activity of group A Streptococcus in pancreatic adenocarcinoma
     
Prasan Kumar Sahoo,
Chang Gung University,
Taiwan
09:30-10:00 Title: Artificial Intelligence Assisted Automatic Localization of Colorectal Cancer Lesion on CT Images
     
H.P. Vasantha Rupasinghe,
Dalhousie University,
Canada
10:00-10:30 Title: Cancer-management therapeutics from dietary flavonoids and their derivatives
     
Refreshment Break (10:30-10:45)
     
Scientific Session III
Morning Session
Session Chairs:
Prasan Kumar Sahoo, Chang Gung University, Taiwan
&
Yongping Bao,
University of East Anglia, United Kingdom
     
Natalia Neparidze &
Poy Theprungsirikul,
Yale University,
United States
10:45-11:15 Title: Real-World Utilization of Daratumumab in Front-Line Treatment of Newly Diagnosed Multiple Myeloma
     
Gioacchin Iannolo,
IRCCS ISMETT,
Italy
11:15-11:35 Title: Zika Virus: A New oncolytic virus for cancer treatment potential. Therapeutic perspectives in Glioblastoma Treatment and implication for other tumors.
     
Yongping Bao,
University of East Anglia,
United Kingdom
11:35-11:55 Title: Dietary Isothiocyanates: Novel Insights into the Potential for Cancer Prevention and Therapy
     
     
John D Schuetz,
St. Jude children's Research Hospital,
USA
11:55-12:15 Title: Mutations in the ABCG2 transporter provide novel functional insights
     
Shanming JI,
University of Strasbourg,
France
12:15-12:35 Title: The Toll signaling pathway plays an essential role in the fly survival upon injection of oncogenic cells
     
Anna Roszkowska,
University of Waterloo,
Canada
12:35-12:55 Title: In vivo solid phase microextraction for therapeutic monitoring of FOLFOX in lung during in vivo lung perfusion 
     
Jong Cheol Jeong,
University of Kentucky,
United States
12:55-13:15 Title: Empowering Cancer Research: The Evolution of Local data Commons in the Era of Next-Generation Sequencing and Artificial Intelligence
(13:15-14:00) Lunch Break @ Restaurant 
     
Afternoon Session
Session Chairs: Jan Dominik Kuhlmann, Technische Universität Dresden, Germany
&
H.P. Vasantha Rupasinghe,
Dalhousie University, Canada
     
Poster presentations (14:00-14:30)
     
Scientific Session IV
     
Gitte Holmen Olofsson,
National Center for Cancer Immune Therapy, CCIT-DK,
Denmark
14:30-14:50 Title: Aiming high in HI-AIM; A clinical testing of exercise in cancer
     
Alisha Dziarski,
Johns Hopkins University,
United States
14:50-15:10 Title: Effect of Area and Individual Social Determinants on Mortality from Hepatocellular Carcinoma
     
Jan Dominik Kuhlmann,
Technische Universität Dresden,
Germany
15:10-15:30 Title: Exploring evolutionary trajectories in ovarian cancer patients by longitudinal analysis of ctDNA
     
Qiao Li,
University of Michigan,
United States
15:30-15:50 Title: Anti-tumor B cells interact with cancer stem cells and exosomal PD-L1
     
Buket Barkana,
The University of Akron,
United States
15:50-16:10 Title: Machine learning-based inflammatory breast cancer diagnosis
     
Omar Benzakour,
University of Poitiers,
France
16:10-16:30 Title: The Vitamin K-Dependent Anticoagulant Factor, Protein S and its tyrosine kinase receptors regulate vascular permeability, angiogenesis and tumor growth
     
Refreshment Break (16:30-16:40)
     
Poster presentations (14:00-14:30)
     
Jianping Chen,
The University of Hong Kong,
Hong Kong
WCCRT-I Title: A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cance
     
Istvan Szasz,
University of Debrecen,
Hungary
WCCRT-II Title: Identification of Lipid Biomarkers Associated with Melanoma Metastasis
     
Viktoria Koroknai,
University of Debrecen,
Hungary
WCCRT-III Title: Cytokine receptor expression in melanoma cell lines induced by dermal endothelial cells
     
Veronika Nemethova,
Comenius University Bratislava,
Slovakia
WCCRT-IV Title: An unconventional therapeutic oligonucleotide effectively eliminates TKI-resistant CML cells
     
Filip Razga,
Comenius University Bratislava,
Slovakia
WCCRT-V Title: Therapeutic oligonucleotide ASP210 effectively reduces the leukemic burden in humanized mice models of CML
     
Pannel Discussions
Conference Hotel:
Hotel Duo,
Teplická 492, 190 00
Prag 9, Czech Republic.
If any one interested to attend the conference or to book your speaker slot, please send an email to   cancercongress@innovincinternational.com

Virtual Agenda

Scientific Program
 Day -2: June (21, 2024)
Virtual Presentations (Time zone: CET)
Marie Vozzo,
Canberra Health Services,
Australia
10:00-10:20 Title: Maternal and foetal risk of radiation-induced cancer from CTPA and V/Q lung scanning for diagnosing pulmonary embolism during pregnancy
Xing-sheng Shu,
Shenzhen University,
China
10:20-10:40 Title: The epigenetic reader ENL controls oncogenic transcription driven by super-enhancer and represents a synergistic vulnerability for BET inhibition
Huiling Li,
Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital,
China
10:40-11:00 Title: PD-L1 expression and prognosis in definitive radiotherapy patients with Neuroendocrine cervical carcinoma
Yang Yang,
Xi'an International Medical Center Hospital,
China
11:00-11:20 Title: Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report
Xin Lu,
University of Notre Dame,
United States
11:20-11:40 Title: Spatial relationship of tertiary lymphoid structures and neutrophils in bladder cancer and prognostic potential for PD-L1 immunotherapy
Pradyumna Ghosh,
IITBHU,
India
11:40-12:00 Title: A novel Approach for Patient Treatment Planning of Localized Cancer
Tekincan Cagri Aktas, Dokuz Eylul University, Turkey 12:00-12:20 Title: Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity 
Sonia Emanuele,
University of Palermo,
Italy
12:20-12:40 Title: The histone deacetylase inhibitor ITF2357 (givinostat) promotes apoptosis in colon cancer cells exploiting long non-coding RNA H19
Jan Lubinski,
Pomeranian Medical University,
Poland
12:40-13:00 Title: Optimisation of selenium in reduction of cancer risk and all-cause mortality
Wojciech Trybus,
Jan Kochanowski University of Kielce,
Poland
13:00-13:20 Title: Quinalizarin induces autophagy, apoptosis and mitotic catastrophe in cervical cancer cells
Katarzyna Supruniuk,
Medical University of Gdansk,
Poland
13:20-13:40 Title: MUC1 mucin and glycosylation of AGS gastric cancer cells are affected by tiliroside
Ewa Trybus,
Jan Kochanowski University of Kielce,
Poland
13:40-14:00 Title: Assessment of the potential anticancer properties of fexofenadine hydrochloride in cervical cancer cells
Enni Markkanen,
University of Zurich,
Switzerland
14:00-14:20 Title: Comprehensive spatially defined transcriptomic and proteomic characterization of human and canine myxo- and fibrosarcoma and their adjacent peritumoral tissue
Brian Jacobsen,
University of Copenhagen,
Denmark
14:20-14:40 Title: Health-economic valuation of lowering nitrate standards in drinking water related to colorectal cancer in Denmark
Nichola Gale,
Cardiff University,
United Kingdom
14:40-15:00 Title: An exploration of physical activity perspectives of people affected by cancer and healthcare professionls to co-design a Cancer, Personalised Activity and Lifestyle tool (CAN-PAL)
Erika Rieti,
I.R.C.C.S. Istituto Tumori "Giovanni Paolo II",
Italy
15:00-15:20 Title: Prevalence and Predictors of Psychological Distress among Italian Cancer Patients Screened with the Translated CHIMP_C Checklist
Andreia Machado Leopoldino,
University of Sao Paulo,
Brazil
15:20-15:40 Title: Spermidine can protect against oral squamous cell carcinoma induced by 4- nitroquinoline 1-oxide in a mouse model
Nitin T Telang,
Palindrome Liaisons Consultants,
United States
15:40-16:00 Title: Dietary phytochemicals and Chinese nutritional herbs as potential drug candidates for breast cancer
Terry Moody,
National Cancer Institute,
United States
16:00-16:20 Title: Peptide G-Protein-coupled receptors and ErbB receptor tyrosine kinases in cancer
Dexiang Gao,
University of Colorado Anschutz Medical Campus,
United States
16:20-16:40 Title: Integrated variant allele frequency analysis pipeline and R package: easyVAF 
Masood A Shammas,
Dana Farber Cancer Institute,
United States
16:40-17:00 Title: Apurinic/apyrimidinic nuclease 1 drives genomic evolution contributing to chemoresistance and tumorigenesis in cancer 
Ady Correa,
University of Miami,
United States
17:00-17:20 Title: Rehabilitation of breast cancer survivors
Julie Stein Deutsch,
Johns Hopkins University,
United States
17:20-17:40 Title: Tissue-Based Biomarkers of Response to Immunotherapy
Maria Krasilnikova,
Pennsylvania State University,
United States
17:40-18:00 Title: A549 lung cancer cells exhibit increased survival in tobacco smoke comparing to normal lung cells
Closing Ceremony
If any one interested to attend the conference or to book your speaker slot, please send an email to   cancercongress@innovincinternational.com
 
Scientific Program
 Day -3: June (22, 2024)
Virtual Presentations (Time zone: CET)
Huawei Li,
Cancer Hospital, School of Medicine, University of Electronic Science and Technology of China,
China
11:00-11:20 Title: Huaier improves the efficacy of anti-PD-L1 Ab in the treatment of hepatocellular carcinoma by regulating tumor immune microenvironment
Ulrik Ringborg,
European Academy of Cancer Sciences,
Sweden
11:20-11:40 Title: The Historical Background of the EU Mission on Cancer 
Anjali Narwal,
Post Graduate Institute of Dental Sciences,
India
11:40-12:00 Title: Association of SOX2, OCT 4 and WNT5A expression in Dysplstic Leukoplakia and Oral Squamous cell carcinoma
Omar Benzakour,
University of Poitiers,
France
12:00-12:20 Title: The Vitamin K-Dependent Anticoagulant Factor, Protein S and its tyrosine kinase receptors regulate vascular permeability, angiogenesis and tumor growth
Helen Pearson,
Cardiff University,
United Kingdom
12:20-12:40 Title: Development of the AR-negative metastatic castration-resistant prostate cancer CU-PC01 Patient Derived Xenograft model
Angela Ragone,
The University Luigi Vanvitelli,
Italy
12:40-13:00 Title: Advancements and Challenges in the Management of Non-Small Cell Lung Cancer: Insights into Immunotherapy
Valerio Papa,
Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University,
Italy
13:00-13:20 Title: The role of Microbiota in Pancreatic Cancer
Giovanna Casili,
University of Messina,
Italy
13:20-13:40 Title: Feasibility of prolyl oligopeptidase (PREP) as tumor biomarker in glioblastoma patients: a pilot study
Masoud Mohammadnezhad,
University of Bradford,
United Kingdom
13:40-14:00 Title: Epidemiology of Cervical Cancer screening in Fiji
Federica Marocchi,
European Institute of Oncology (IEO),
Italy
14:00-14:20 Title: Actionable Genetic Screens Unveil Targeting of AURKA, MEK, and Fatty Acid Metabolism as an Alternative Therapeutic Approach for Advanced Melanoma
Frederique Vegran,
Burgundy Franche-Comté University,
France
14:20-14:40 Title: The tumor microenvironment impairs Th1 IFNγ secretion through alternative splicing modifications of Irf1
Alix Carter,
EHS NS/Western University,
Canada
14:40-15:00 Title: Understanding differences in paramedic palliative care for people with cancer compared with non-cancer advanced disease
Anna Prizment,
University of Minnesota,
United States
15:00-15:20 Title: Proteomic aging clock as a biomarker for mortality in cancer survivors
Shoshanna N. Zucker,
D'Youville University School of Pharmacy,
United States
15:20-15:40 Title: A Novel, Highly Selective RONS-Inducing Therapy to Treat Melanoma
Richard G Pestell,
Baruch S Blumberg Institute,
United States
15:40-16:00 Title: The DACH1 gene is frequently co-deleted with BRCA2 in prostate cancer and governs PARP inhibitor resistance
Michael Goldstein,
Johns Hopkins University,
United States
16:00-16:20 Title: Targeting H3K27me3 loss in pediatric brain tumors - a perspective on epigenetically guided cancer therapy
Cuihua Liu,
Bio-Thera Solutions Ltd,
China
16:20-16:40 Title: Physicochemical and Functional Similarity Assessment between Proposed Bevacizumab Biosimilar BAT1706 and Reference Bevacizumab
Richard G Pestell,
Baruch S Blumberg Institute,
United States
16:40-17:00 Title: A cyclin D1 intrinsically disordered domain accesses modified histone motifs to
govern gene transcription
Closing Ceremony
If any one interested to attend the conference or to book your speaker slot, please send an email to   cancercongress@innovincinternational.com

Download